Correlation Between Willow Biosciences and Medipharm Labs

Can any of the company-specific risk be diversified away by investing in both Willow Biosciences and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Willow Biosciences and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Willow Biosciences and Medipharm Labs Corp, you can compare the effects of market volatilities on Willow Biosciences and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Willow Biosciences with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Willow Biosciences and Medipharm Labs.

Diversification Opportunities for Willow Biosciences and Medipharm Labs

-0.22

Correlation Coefficient

Willow Biosciences  Medipharm Labs

Very good diversification

The 3 months correlation between Willow and Medipharm is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Willow Biosciences and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Willow Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Willow Biosciences are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Willow Biosciences i.e., Willow Biosciences and Medipharm Labs go up and down completely randomly.

Pair Corralation between Willow Biosciences and Medipharm Labs

Assuming the 90 days trading horizon Willow Biosciences is expected to under-perform the Medipharm Labs. But the stock apears to be less risky and, when comparing its historical volatility, Willow Biosciences is 1.11 times less risky than Medipharm Labs. The stock trades about -0.08 of its potential returns per unit of risk. The Medipharm Labs Corp is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  6.50  in Medipharm Labs Corp on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Medipharm Labs Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Willow Biosciences  vs.  Medipharm Labs Corp

Willow Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Willow Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Medipharm Labs Corp

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Medipharm Labs Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Medipharm Labs may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Willow Biosciences and Medipharm Labs

The main advantage of trading using opposite Willow Biosciences and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Willow Biosciences position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.

The idea behind Willow Biosciences and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.